Library / Laws / 118th Congress / House Bills / H.R. 3008
H.R. 3008
To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical essential medicines of increased demand of such drugs, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2023-04-28 | 7.7K | ⠃⠗⠋ |